Okamoto Hiroshi, Nishi Takeshi, Kamisaka Kyo, Sasahira Yoshitaka, Kanaoka Koshiro, Sumita Yoko, Iwanaga Yoshitaka, Izumi Chisato, Uemura Shiro
Department of Cardiology Kawasaki Medical School Kurashiki Japan.
Department of Cardiovascular Medicine Chiba University Graduate School of Medicine Chiba Japan.
J Am Heart Assoc. 2025 Jan 7;14(1):e037188. doi: 10.1161/JAHA.124.037188. Epub 2024 Dec 31.
Infective endocarditis (IE) is still a fatal disease, and given its rarity, ongoing updates to patient characteristics and outcomes of IE are essential for providing precision diagnoses and effective treatments. This study sought to examine temporal trends in the clinical characteristics and in-hospital occurrence of adverse outcomes of IE.
Using the Japan nationwide administrative database, we identified patients with IE in Japan from 2016 to 2021. A total of 17 407 patients with IE (37.8% women; median age, 72 [interquartile range, 59-81] years) were identified. The incidence of IE increased from 2.02 per 100 000 population in 2016 to 2.59 per 100 000 population in 2021. The median age of the patients increased from 70 years in 2016 to 73 years in 2021, and patient backgrounds were becoming more complex. The in-hospital mortality rate was 14.5%, which significantly increased from 14.1% in 2016 to 15.4% in 2021. Higher age (odds ratio [OR], 1.34 [95% CI, 1.29-1.40]), heart failure (OR, 1.37 [95% CI, 1.18-1.59]), cerebrovascular complications (OR, 1.78 [95% CI, 1.59-1.99]), renal failure (OR, 2.36 [95% CI, 2.06-2.70]), and sepsis (OR, 2.79 [95% CI, 2.48-3.13]), were independently associated with an increased in-hospital mortality rate. In contrast, cardiac surgery (OR, 0.47 [95% CI, 0.41-0.55]), and a higher number of total cardiac surgeries (OR, 0.77 [95% CI, 0.65-0.92]) independently predicted a lower in-hospital mortality rate.
The characterization and comprehensive analysis of IE in Japan provides valuable insights into the epidemiology, risk factors, and outcomes of IE, which may inform health service planning and treatment strategies.
感染性心内膜炎(IE)仍然是一种致命疾病,鉴于其罕见性,不断更新IE患者的特征和预后对于提供精准诊断和有效治疗至关重要。本研究旨在探讨IE临床特征和不良预后院内发生率的时间趋势。
利用日本全国行政数据库,我们确定了2016年至2021年期间日本的IE患者。共识别出17407例IE患者(女性占37.8%;中位年龄72岁[四分位间距,59 - 81岁])。IE的发病率从2016年的每10万人2.02例增至2021年的每10万人2.59例。患者的中位年龄从2016年的70岁增至2021年的73岁,且患者背景日益复杂。院内死亡率为14.5%,从2016年的14.1%显著增至2021年的15.4%。高龄(比值比[OR],1.34[95%置信区间,1.29 - 1.40])、心力衰竭(OR,1.37[95%置信区间,1.18 - 1.59])、脑血管并发症(OR,1.78[95%置信区间,1.59 - 1.99])、肾衰竭(OR,2.36[95%置信区间,2.06 - 2.70])和脓毒症(OR,2.79[95%置信区间,2.48 - 3.13])与院内死亡率增加独立相关。相反,心脏手术(OR,0.47[95%置信区间,0.41 - 0.55])以及心脏手术总数较多(OR,0.77[95%置信区间,0.65 - 0.92])独立预测较低的院内死亡率。
对日本IE的特征描述和综合分析为IE的流行病学、危险因素和预后提供了有价值的见解,这可能为卫生服务规划和治疗策略提供参考。